Drug recall D-1507-2020
Product
Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Aventis U. S. LLC Bridgewater, NJ, 08807, NDC 0024-5151-75
Reason for recall
Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.
Lots and codes
Lot #: A9306, Exp 2/28/2022
Recall details
- Recalling firm
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Quantity
- 7451 vials
- Distribution
- Nationwide in the US
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 10, 2020
Related products
- Elitek – drug information
- NDC 0024-5151 Elitek · · Sanofi-Aventis U.S. LLC
- NDC 0024-5150 Elitek · · Sanofi-Aventis U.S. LLC